2025 |
Phathom Pharmaceuticals Inc
|
Director, President and Chief Executive Officer |
- |
- |
2024 |
VYNE Therapeutics Inc
|
Independent Director |
- |
- |
2024 |
Phathom Pharmaceuticals Inc
|
President, Chief Executive Officer and Director |
- |
- |
2023 |
VYNE Therapeutics Inc
|
Independent Director |
83.6 K |
89.6 % |
2022 |
VYNE Therapeutics Inc
|
Director |
44.1 K |
-40.9 % |
2021 |
VYNE Therapeutics Inc
|
Director |
74.6 K |
-43.9 % |
2020 |
VYNE Therapeutics Inc
|
Director |
133.0 K |
- |
2019 |
VYNE Therapeutics Inc
|
Director |
- |
- |
2018 |
VYNE Therapeutics Inc
|
President, Chief Executive Officer and Director |
- |
- |
2017 |
KalVista Pharmaceuticals Inc
|
- |
33.3 K |
- |
2017 |
VYNE Therapeutics Inc
|
President, Chief Executive Officer and Director |
- |
- |
2016 |
KalVista Pharmaceuticals Inc
|
Independent Director |
- |
- |
2016 |
VYNE Therapeutics Inc
|
President, Chief Executive Officer and Director |
- |
- |
2015 |
KalVista Pharmaceuticals Inc
|
Independent Director |
99.7 K |
152.5 % |
2014 |
KalVista Pharmaceuticals Inc
|
Independent Director |
39.5 K |
- |